This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co., Ltd., Medshine Discovery Inc.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: Innovations by Inventor Yang Yue in Anti-Tumor Pharmaceutical Development
Introduction: Yang Yue is a notable inventor based in Wuhan, China, recognized for his contributions to the field of pharmaceuticals. With a portfolio of three patents, Yang has made significant strides in creating innovative compounds aimed at combating cancer. His inventions reflect a commitment to advancing medical science and improving patient outcomes.
Latest Patents: Among Yang Yue's latest patents is a groundbreaking pyrimidine derivative designed for use as an anaplastic lymphoma kinase (ALK) inhibitor. This compound, illuminated by its specific chemical formula, holds promise as an effective anti-tumor medicament. Furthermore, he has developed a series of Bruton's Tyrosine Kinase (BTK) inhibitors, which include various compounds and their pharmaceutically acceptable salts. These innovations underscore Yang's focus on targeting critical pathways involved in cancer progression.
Career Highlights: Yang has held prominent roles in leading organizations such as the Hubei Bio-pharmaceutical Industrial Technological Institute and Humanwell Healthcare Group. These affiliations have enabled him to push the boundaries of pharmaceutical research and translate scientific findings into viable medical applications. His dedication to innovation reflects the dynamic nature of the biotechnology sector.
Collaborations: Throughout his career, Yang Yue has had the privilege of collaborating with esteemed colleagues such as Xuehai Wang and Yong Xu. These partnerships have fostered an environment of creativity and knowledge sharing, contributing to the advancement of novel therapeutic solutions in the healthcare industry.
Conclusion: Yang Yue stands as a prominent figure in the field of pharmaceutical innovation. His three patents, including important advancements in ALK and BTK inhibitors, showcase his commitment to developing impactful cancer therapies. Through his career and collaborations, Yang continues to shape the future of medicine, making significant contributions to the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile